“March 10, 1997 Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

The field of automated cytology is advancing quickly. Technology is rapidly pushing into the marketplace. Here’s a sampling of recent developments among cytology-based companies…

Cytyc Corporation and Laboratory Corporation of America announced on March 6 that a national contract had been signed between the two companies. LabCorp will make Cytyc’s ThinPrep® Pap smear available to physicians throughout the country.

MORE ON: Cytyc…
The company’s Premarket Approval Application (PMA) Supplement was approved last month by the FDA to allow the use of the endocervical brush and plastic spatula for collection with the ThinPrep system. This will make it easier for Cytyc to get physicians to use Thin Prep, as these collection devices are in common usage.

NeoPath, Inc. was granted four additional patents used in its AutoPap® technology. The company now has 18 U.S. patents issued or allowed, with 25 patents pending.

Neuromedical Systems, Inc. released results of a new study. At the annual meeting of the Unite d States and Canada Academy of Pathology, it was reported that Neuromedical’s PapNet® System was able to detect cancerous and precancerous cells of the esophagus on conventionally prepared slides. In a study done by Leopold G. Koss, M.D. of Montefiore Medical Center in New York, 138 esophageal smears were reviewed. PapNet correctly identified all 36 patients who were positive or suspicious of cancer. The system also diagnosed two additional patient s not previously considered diagnostic.


AccuMed, Inc. has begun shipping its AcCell® and TracCell® systems to Europe under a contract with Leica Microscopy and Systems GmbH. Leica will distribute Accumed’s products in Europe. AccuMed is the latest of the automated cytology companies to actively develop over seas markets for its products.


Smart laboratory administrators should take the time to look at Roche Diagnostic Systems’ new instrument, the COBAS Integra. It is a multi-test, random access machine capable of 72 different tests. One commercial lab manager told THE DARK REPORT that he was able to eliminate 17 instruments in his lab by consolidating specimen flow around the Integra.


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.